GE HealthCare Technologies Inc. (NASDAQ:GEHC) Receives Consensus Rating of “Hold” from Analysts

Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) have earned a consensus rating of “Hold” from the fourteen brokerages that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, six have assigned a hold rating and seven have assigned a buy rating to the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $92.1667.

A number of analysts have recently weighed in on the company. Evercore raised their price objective on GE HealthCare Technologies from $95.00 to $98.00 and gave the stock an “outperform” rating in a research report on Thursday, February 5th. Citigroup decreased their price target on GE HealthCare Technologies from $88.00 to $84.00 and set a “neutral” rating for the company in a research note on Wednesday, March 11th. Stifel Nicolaus raised their price target on GE HealthCare Technologies from $95.00 to $98.00 and gave the stock a “buy” rating in a report on Wednesday, February 4th. Piper Sandler upped their price objective on shares of GE HealthCare Technologies from $91.00 to $94.00 and gave the company an “overweight” rating in a report on Friday, January 30th. Finally, BTIG Research reaffirmed a “buy” rating and issued a $91.00 price objective on shares of GE HealthCare Technologies in a research report on Thursday, March 19th.

Institutional Investors Weigh In On GE HealthCare Technologies

Several institutional investors and hedge funds have recently made changes to their positions in GEHC. Western Wealth Management LLC raised its stake in GE HealthCare Technologies by 2.4% in the 4th quarter. Western Wealth Management LLC now owns 5,240 shares of the company’s stock worth $430,000 after acquiring an additional 125 shares during the last quarter. United Community Bank grew its stake in GE HealthCare Technologies by 10.2% during the 4th quarter. United Community Bank now owns 1,410 shares of the company’s stock valued at $116,000 after purchasing an additional 130 shares during the last quarter. Parkside Financial Bank & Trust increased its holdings in shares of GE HealthCare Technologies by 3.9% in the fourth quarter. Parkside Financial Bank & Trust now owns 3,567 shares of the company’s stock valued at $293,000 after purchasing an additional 134 shares during the period. Thoma Capital Management LLC increased its holdings in shares of GE HealthCare Technologies by 1.4% in the fourth quarter. Thoma Capital Management LLC now owns 9,918 shares of the company’s stock valued at $814,000 after purchasing an additional 136 shares during the period. Finally, True North Advisors LLC raised its stake in shares of GE HealthCare Technologies by 2.0% in the third quarter. True North Advisors LLC now owns 6,987 shares of the company’s stock worth $525,000 after purchasing an additional 139 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Trading Down 3.2%

NASDAQ GEHC opened at $69.23 on Friday. GE HealthCare Technologies has a 52 week low of $57.65 and a 52 week high of $89.77. The company has a 50 day moving average price of $77.91 and a 200 day moving average price of $78.26. The company has a quick ratio of 1.13, a current ratio of 1.37 and a debt-to-equity ratio of 0.91. The firm has a market cap of $31.59 billion, a PE ratio of 15.18, a price-to-earnings-growth ratio of 1.52 and a beta of 1.03.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.04. The company had revenue of $5.70 billion during the quarter, compared to the consensus estimate of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. GE HealthCare Technologies’s revenue was up 7.1% compared to the same quarter last year. During the same period last year, the firm earned $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, sell-side analysts forecast that GE HealthCare Technologies will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be paid a dividend of $0.035 per share. The ex-dividend date is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is presently 3.07%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.